Announcement PDF 16 February 2018 Market Announcements Australian Securities Exchange Limited 20 Bridge Street Sydney NSW 2000 By Electronic Lodgement Dear Sir/Madam Results of General Meeting – Recce Pharmaceuticals Ltd (Company) In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the resolutions and the proxies received in respect of each resolution as set out in the attached proxy summary. Both resolutions considered at today's General Meeting were passed on a unanimous show of hands; 94% of the Open-Usable Proxies had been given to the Board who all voted to pass both resolutions. Therefore, both Michele Dilizia and James Graham have been re-elected as Directors of the Company. Yours faithfully Alistair McKeough Company Secretary Recce Pharmaceuticals Ltd General Meeting Friday, 16 February 2018 Voting Results The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth). Resolution details Resolution Resolution Type 1 Re-election of Director - Michele Dilizia Ordinary 2 Re-election of Director - James Graham Ordinary Instructions given to validly appointed proxies (as at proxy close) Proxy's For Against Abstain Discretion 39,873,768 340,249 744,497 117,285 97.35% 0.83% 1.82% 39,883,768 97.37% 330,249 0.81% 744,497 1.82% * Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll. 117,285 Number of votes cast on the poll (where applicable) For Against Abstain* Resolution Result Carried / Not Carried Carried on a show of hands Carried Carried on a show of hands Carried